Compare Adaptive Biotechnologies Corp (ADPT) vs Cipher Mining Inc (CIFR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Cipher Mining Inc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Cipher Mining Inc trades at $21.85 (market cap $8.41B). The key difference: Cipher Mining Inc is far larger — about 2.5× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Cipher Mining Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | CIFR | |
|---|---|---|
Market Cap | $3.33B | $8.41B |
Sector | Health | Basic Materials |
52-Week High | $22.37 | $29.18 |
52-Week Low | $10.24 | $4.72 |
Enterprise Value | $3.19B | $12.45B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CIFR trades at $21.73, up 8.43% today but remains in a bearish technical trend. The company is transitioning from Bitcoin mining to AI data center operations, with $11.4B in contracted lease revenue from AWS and Fluidstack. Despite strong analyst support (13 buy ratings), fundamentals show deep losses with -427.79% net margin and negative cash flow from operations.
The investment case hinges on successful execution of the AI infrastructure pivot, with revenue expected to ramp from 2027. Key risks include high valuation multiples, negative profitability, and execution challenges in data center deployment. The consensus price target of $31.61 suggests 45% upside if the transition succeeds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Cipher Mining Inc
Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.
Read more on CIFR →
